Condition | Non-exertional soreness | Exertional soreness | |
FM | Acute onset | DOMS | |
Previous exertional events | No | Yes | Yes |
Onset | Chronic | Immediate6 | Subacute2 6 |
Duration | >3 months7 | Hours6 | 5–7 days26 |
Inflammation or tissue insults | No7 8 | Yes6 | Yes2 6 |
Distribution | Widespread7 8 | Localised to exertion sites6 | Localised to exertion sites2 6 |
Correlation with myalgia | |||
Intensity | Yes | Yes6 25 | Yes6 25 |
Localisation | No | Yes6 | Yes2 6 |
Muscle fatigue | Yes7 | Yes6 | Yes2 6 |
Clinical impact | |||
Stiffness | Yes | Yes6 26 | Yes2 6 26 |
Restless condition | Yes | Undetermined | Undetermined |
Metabolic changes | |||
Lactate levels | Decreased (vs HC) | Increased6 | Non-increased2 6 |
Oxidative status | Increased12 14 15 18 | Increased6 34 | Uncertain2 6 24 |
Pharmacotherapy | Unavailable | NSAID6 | NSAID2 6 |
DOMS, delayed onset muscle soreness; FM, fibromyalgia; HC, healthy control; NSAID, non-steroid anti-inflammatory drug.